KEAP1 and Hyperglycemia: Our in vitro and in vivo studies revealed that hyperglycemia significantly increased Keap1 expression and inhibited Nrf2 and NQO1 expression, whereas PET treatment reversed these trends and improved oxidative stress and ferroptosis.